Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Zimmer Biomet Holdings (ZBH), PTC Therapeutics (PTCT) and Jounce Therapeutics (JNCE).
Zimmer Biomet Holdings (ZBH)
Raymond James analyst Lawrence Keusch maintained a Buy rating on Zimmer Biomet Holdings yesterday and set a price target of $200.00. The company’s shares closed last Tuesday at $172.93, close to its 52-week high of $180.36.
According to TipRanks.com, Keusch is a 4-star analyst with an average return of 6.4% and a 66.7% success rate. Keusch covers the Healthcare sector, focusing on stocks such as Baxter International, Intuitive Surgical, and Becton Dickinson.
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Zimmer Biomet Holdings with a $187.47 average price target, representing a 7.8% upside. In a report released yesterday, Oppenheimer also maintained a Buy rating on the stock with a $195.00 price target.
See today’s analyst top recommended stocks >>
PTC Therapeutics (PTCT)
Raymond James analyst Danielle Brill reiterated a Buy rating on PTC Therapeutics yesterday and set a price target of $70.00. The company’s shares closed last Tuesday at $38.47, close to its 52-week low of $38.01.
According to TipRanks.com, Brill is a 4-star analyst with an average return of 12.9% and a 49.3% success rate. Brill covers the Healthcare sector, focusing on stocks such as Global Blood Therapeutics, ACADIA Pharmaceuticals, and Sarepta Therapeutics.
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for PTC Therapeutics with a $65.17 average price target, which is a 59.4% upside from current levels. In a report released yesterday, William Blair also maintained a Buy rating on the stock.
Jounce Therapeutics (JNCE)
Raymond James analyst Steven Seedhouse maintained a Hold rating on Jounce Therapeutics yesterday. The company’s shares closed last Tuesday at $8.53.
According to TipRanks.com, Seedhouse is a 3-star analyst with an average return of 6.5% and a 42.1% success rate. Seedhouse covers the Healthcare sector, focusing on stocks such as Madrigal Pharmaceuticals, Alexion Pharmaceuticals, and Apellis Pharmaceuticals.
Jounce Therapeutics has an analyst consensus of Moderate Buy, with a price target consensus of $16.00.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
